Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Gene Variant rs11030119 Impacts BDNF Platelet Function

June 24, 2026
Continue Reading
gene-variant-rs11030119-impacts-bdnf-platelet-function
Posted inBiotechnology

Decades of Data Reveal Which Orcas Call Puget Sound Home

June 24, 2026
Continue Reading
decades-of-data-reveal-which-orcas-call-puget-sound-home
Posted inBiotechnology

Introducing a Revolutionary Pixel Technology

June 24, 2026
Continue Reading
introducing-a-revolutionary-pixel-technology
Posted inBiotechnology

Plasma Technology Extends Catalyst Lifespan in Hydrogen Production

June 24, 2026
Continue Reading
plasma-technology-extends-catalyst-lifespan-in-hydrogen-production
Posted inBiotechnology

Mesoporous Membranes Revolutionize Crude Oil Fractionation

June 24, 2026
Continue Reading
mesoporous-membranes-revolutionize-crude-oil-fractionation
Posted inBiotechnology

Acute Psychedelic Effects on Brain Entropy Revealed

June 24, 2026
Continue Reading
acute-psychedelic-effects-on-brain-entropy-revealed
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

former-seagen-ceo’s-biotech-raises-$140m-series-a-to-ready-pd1/vegfr2-antibody-for-clinic
Posted inBiotechnology

Former Seagen CEO’s biotech raises $140M series A to ready PD1/VEGFR2 antibody for clinic

December 19, 2024
Two months after former Seagen CEO David Epstein unveiled his new project, the biotech has secured "over" $140 million in…
Read More
fda-elevates-boston-scientific-cryoablation-correction-effort-following-four-deaths
Posted inMedical Technology

FDA elevates Boston Scientific cryoablation correction effort following four deaths

December 19, 2024
The FDA is elevating a recall from Boston Scientific covering its cryoablation balloon catheters for the treatment of atrial fibrillation.…
Read More
bms-pays-leqembi-originator-$100m-for-next-gen-preclinical-alzheimer’s-prospects
Posted inBiotechnology

BMS pays Leqembi originator $100M for next-gen preclinical Alzheimer’s prospects

December 19, 2024
Bristol Myers Squibb has turned to the source of Leqembi to further its push into Alzheimer’s disease, paying BioArctic $100 million…
Read More
roche-reports-failure-of-prothena-partnered-parkinson’s-prospect-in-phase-2b-but-highlights-positives
Posted inBiotechnology

Roche reports failure of Prothena-partnered Parkinson’s prospect in phase 2b but highlights positives

December 19, 2024
Back-to-back clinical failures have dealt further blows to efforts to treat Parkinson’s disease by targeting alpha-synuclein. Days after UCB reported the…
Read More
astellas-pays-sangamo-$20m-upfront-to-improve-neurological-gene-therapy-capabilities
Posted inBiotechnology

Astellas pays Sangamo $20M upfront to improve neurological gene therapy capabilities

December 19, 2024
Astellas is continuing to strengthen its neurological disease gene therapy capabilities, handing Sangamo Therapeutics $20 million upfront to help bypass…
Read More
akamis-bio-raises-$60-million-for-cancer-gene-therapy,-signs-licensing-deal-with-xuanzhu-biopharma
Posted inGenetics

Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma

December 19, 2024
Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of…
Read More
mechanisms-underlying-sjogren’s-disease-outlined-in-mice;-existing-drug-shows-therapeutic-promise
Posted inGenetics

Mechanisms Underlying Sjögren’s Disease Outlined in Mice; Existing Drug Shows Therapeutic Promise

December 19, 2024
Researchers at NYU College of Dentistry and NYU Grossman School of Medicine reported the findings of a study in mice…
Read More
how-fungi-make-a-promising-compound-for-treating-cancer-and-inflammation
Posted inGenetics

How Fungi Make a Promising Compound for Treating Cancer and Inflammation

December 18, 2024
The process by which fungi synthesize some of their most potent compounds has remained unclear for many years. This is…
Read More
xgen-venture-closes-$190m-fund-with-plans-to-invest-in-early-stage-biotech,-medtech-firms
Posted inBiotechnology

XGEN Venture closes $190M fund with plans to invest in early-stage biotech, medtech firms

December 18, 2024
Italian VC XGEN Venture has closed a 180 million euro ($190 million) fund for biotech and medtech companies. The life…
Read More
labcorp-launches-bird-flu-test-amid-first-severe-case-in-the-us
Posted inMedical Technology

Labcorp launches bird flu test amid first severe case in the US

December 18, 2024
Amid reports of the first severe human case of bird flu in the U.S., Labcorp has launched a molecular diagnostic…
Read More

Posts pagination

Previous page 1 … 1,999 2,000 2,001 2,002 2,003 … 2,012 Next page
You May Have Missed
abbott-pens-blood-based-alzheimer’s-testing-pact-with-alzpath
Posted inMedical Technology

Abbott pens blood-based Alzheimer’s testing pact with ALZpath

insulet-hires-convatec,-eli-lilly-alum-as-new-r&d-chief
Posted inMedical Technology

Insulet hires Convatec, Eli Lilly alum as new R&D chief

access-vascular-taps-medline-to-help-roll-out-new-line-of-catheters
Posted inMedical Technology

Access Vascular taps Medline to help roll out new line of catheters

fda-issues-early-alert-for-j&j’s-abiomed-catheter-introducer-over-manufacturing-issues,-bleeding-risk
Posted inMedical Technology

FDA issues early alert for J&J’s Abiomed catheter introducer over manufacturing issues, bleeding risk

Privacy Policy    Terms

Scroll to Top